These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 3317056

  • 21. Melphalan and total body irradiation (TBI) versus cyclophosphamide and TBI as conditioning for allogeneic matched sibling bone marrow transplants for acute myeloblastic leukaemia in first remission.
    Helenglass G, Powles RL, McElwain TJ, Lakhani A, Milan S, Gore M, Nandi A, Zuiable A, Perren T, Forgeson G.
    Bone Marrow Transplant; 1988 Jan; 3(1):21-9. PubMed ID: 3048467
    [Abstract] [Full Text] [Related]

  • 22. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A, Iori A, Guglielmi C, Romano A, Cerretti R, Torromeo C, Micozzi A, Fenu S, Laurenti L, Donato V, De Felice L, Arcese W.
    Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
    [Abstract] [Full Text] [Related]

  • 23. Is veno-occlusive disease incidence influenced by the total-body irradiation technique?
    Belkacémi Y, Ozsahin M, Rio B, Laporte JP, Leblond V, Pène F, Laugier A.
    Strahlenther Onkol; 1995 Dec; 171(12):694-7. PubMed ID: 8545791
    [Abstract] [Full Text] [Related]

  • 24. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ, Díaz de Heredia C, Olivé T, Bastida P, Llort A, Armadans L, Torrabadella M, Massuet L.
    Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
    [Abstract] [Full Text] [Related]

  • 25. [Allogenic transplantation of hematopoietic stem cells in the treatment of children with high-risk acute leukemia].
    Starý J, Kobylka P, Sedlácek P, Komrska V, Vávra V, Syrůcková Z, Smísek P, Hrubá A, Korínková P, Matĕjková E, Cukrová V, Dolezalová L, Loudová M, Sejkorová J, Kvĕch J.
    Cas Lek Cesk; 1998 Jun 15; 137(12):363-7. PubMed ID: 9721472
    [Abstract] [Full Text] [Related]

  • 26. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.
    Zittoun RA, Mandelli F, Willemze R, de Witte T, Labar B, Resegotti L, Leoni F, Damasio E, Visani G, Papa G.
    N Engl J Med; 1995 Jan 26; 332(4):217-23. PubMed ID: 7808487
    [Abstract] [Full Text] [Related]

  • 27. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F, Copelan E, Crilley P, Bolwell B, Avalos B, Klein J, Territo M, Gajewski J.
    Bone Marrow Transplant; 1996 May 26; 17(5):685-9. PubMed ID: 8733682
    [Abstract] [Full Text] [Related]

  • 28. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
    Long GD, Amylon MD, Stockerl-Goldstein KE, Negrin RS, Chao NJ, Hu WW, Nademanee AP, Snyder DS, Hoppe RT, Vora N, Wong R, Niland J, Reichardt VL, Forman SJ, Blume KG.
    Biol Blood Marrow Transplant; 1997 Dec 26; 3(6):324-30. PubMed ID: 9502300
    [Abstract] [Full Text] [Related]

  • 29. High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
    Zander AR, Berger C, Kröger N, Stockshläder M, Krüger W, Horstmann M, Grimm J, Zeller W, Kabisch H, Erttmann R, Schönrock P, Kuse R, Braumann D, Illiger HJ, Fiedler W, de Witt M, Hossfeld KD, Weh HJ.
    Clin Cancer Res; 1997 Dec 26; 3(12 Pt 2):2671-5. PubMed ID: 10068272
    [Abstract] [Full Text] [Related]

  • 30. Outcome of second bone marrow transplantation following a uniform conditioning regimen as therapy for malignant relapse.
    Chiang KY, Weisdorf DJ, Davies SM, Enright H, Kersey JH, McGlave PB, Miller W, Ramsay NK, Steinbuch M, Wagner JE, Blazar BR.
    Bone Marrow Transplant; 1996 Jan 26; 17(1):39-42. PubMed ID: 8673052
    [Abstract] [Full Text] [Related]

  • 31. Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide.
    Duerst RE, Horan JT, Liesveld JL, Abboud CN, Zwetsch LM, Senf ES, Constine LS, Raubertas RF, Passarell JA, DiPersio JF.
    Bone Marrow Transplant; 2000 Mar 26; 25(5):489-94. PubMed ID: 10713624
    [Abstract] [Full Text] [Related]

  • 32. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
    Frassoni F, Labopin M, Gluckman E, Prentice HG, Vernant JP, Zwaan F, Granena A, Gahrton G, De Witte T, Gratwohl A, Reiffers J, Gorin NC.
    Bone Marrow Transplant; 1996 Jan 26; 17(1):13-8. PubMed ID: 8673048
    [Abstract] [Full Text] [Related]

  • 33. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T, Aisa Y, Watanabe R, Yamazaki R, Kato J, Shimizu T, Shigematsu N, Kubo A, Yajima T, Hibi T, Ikeda Y, Okamoto S.
    Biol Blood Marrow Transplant; 2008 Jun 26; 14(6):651-7. PubMed ID: 18489990
    [Abstract] [Full Text] [Related]

  • 34. Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission.
    Lee SH, Lee MH, Lee JH, Min YH, Lee KH, Cheong JW, Lee J, Park KW, Kang JH, Kim K, Kim WS, Jung CW, Choi SJ, Lee JH, Park K.
    Biol Blood Marrow Transplant; 2005 Feb 26; 11(2):122-8. PubMed ID: 15682073
    [Abstract] [Full Text] [Related]

  • 35. HLA-identical haematopoietic stem cell transplantation for acute leukaemia in children: less relapse with higher biologically effective dose of TBI.
    Willemze AJ, Geskus RB, Noordijk EM, Kal HB, Egeler RM, Vossen JM.
    Bone Marrow Transplant; 2007 Aug 26; 40(4):319-27. PubMed ID: 17572715
    [Abstract] [Full Text] [Related]

  • 36. Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide.
    Yeager AM, Kaizer H, Santos GW, Saral R, Colvin OM, Stuart RK, Braine HG, Burke PJ, Ambinder RF, Burns WH.
    N Engl J Med; 1986 Jul 17; 315(3):141-7. PubMed ID: 3523241
    [Abstract] [Full Text] [Related]

  • 37. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts.
    Weiden PL, Flournoy N, Thomas ED, Prentice R, Fefer A, Buckner CD, Storb R.
    N Engl J Med; 1979 May 10; 300(19):1068-73. PubMed ID: 34792
    [Abstract] [Full Text] [Related]

  • 38. Allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moelle.
    Michel G, Gluckman E, Esperou-Bourdeau H, Reiffers J, Pico JL, Bordigoni P, Thuret I, Blaise D, Bernaudin F, Jouet JP.
    J Clin Oncol; 1994 Jun 10; 12(6):1217-22. PubMed ID: 8201385
    [Abstract] [Full Text] [Related]

  • 39. T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease.
    Papadopoulos EB, Carabasi MH, Castro-Malaspina H, Childs BH, Mackinnon S, Boulad F, Gillio AP, Kernan NA, Small TN, Szabolcs P, Taylor J, Yahalom J, Collins NH, Bleau SA, Black PM, Heller G, O'Reilly RJ, Young JW.
    Blood; 1998 Feb 01; 91(3):1083-90. PubMed ID: 9446672
    [Abstract] [Full Text] [Related]

  • 40. Bone marrow transplantation for acute leukemia: recent advances and comparison with alternative therapies.
    Champlin R, Gale RP.
    Semin Hematol; 1987 Jan 01; 24(1):55-67. PubMed ID: 3547673
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.